Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-001878
Filing Date
2023-01-05
Accepted
2023-01-05 16:33:17
Documents
1
Period of Report
2023-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4023
  Complete submission text file 0001209191-23-001878.txt   5457
Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JANUX THERAPEUTICS, INC. 11099 N. TORREY PINES ROAD, SUITE 290 LA JOLLA CA 92037
Business Address
Meyer Andrew Hollman (Reporting) CIK: 0001864159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 23511917